Related Experiment Video
Updated: May 27, 2026
07:52
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Cell-based therapies for lung vascular diseases: lessons for the future
Duncan J Stewart1, Shirley H J Mei
1Ottawa Hospital Research Institute, The Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K1H 8L6 Canada. djstewart@ohri.ca
Proceedings of the American Thoracic Society
|November 5, 2011
Summary
Cellular therapies show promise for treating lung diseases like pulmonary arterial hypertension and acute respiratory distress syndrome (ARDS) by repairing vascular damage and reducing inflammation. Combining cell and gene therapy may enhance treatment effectiveness.
Area of Science:
- Pulmonary medicine
- Regenerative medicine
- Vascular biology
Background:
- Pulmonary arterial hypertension (PAH) and acute respiratory distress syndrome (ARDS) stem from lung endothelial injury and inflammation.
- PAH involves pathological changes in small pulmonary arteries, including fibrosis and plexiform lesions.
- ARDS is a critical complication of acute lung injury, marked by air-blood barrier disruption and inflammation.
Purpose of the Study:
- To explore the potential of cellular therapies for treating PAH and ARDS.
- To investigate the mechanisms by which stem cells may exert therapeutic effects.
- To evaluate the benefits of combining cell and gene therapy for enhanced regenerative function.
Main Methods:
- Review of preclinical studies on cellular therapies for respiratory diseases.
- Analysis of mesenchymal stem cell and progenitor cell therapeutic mechanisms.
- Exploration of combined cell and gene therapy approaches.
Main Results:
- Cellular therapies, particularly using stem cells, show potential for vascular repair and regeneration.
- Stem cells may modulate immune responses, offering therapeutic benefits.
- Combined cell and gene therapy could enhance regenerative capacity and overcome limitations of single therapies.
Conclusions:
- Cellular therapies represent a promising alternative for treating lung vascular diseases with limited options.
- Mesenchymal stem cells show potential for promoting vascular repair and immunomodulation.
- Enhanced cell therapy, potentially through genetic engineering, may offer improved outcomes for PAH and ARDS.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.